Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Ravenquest Biomed Inc RVVQF

Ravenquest BioMed Inc is a Canada-based diversified cannabis company with divisions focused upon cannabis production, management services and consulting and specialized research and development. It provides integrated solutions to companies in the cannabis industry and provides growing and drying technologies, patient and genetic management systems, and security management solutions The company operates through the following segments - Consulting business and Cultivation and Sale of Medical Cannabis.


GREY:RVVQF - Post by User

Post by ourrugon Jul 02, 2019 9:51pm
109 Views
Post# 29881767

Top 8 Takeaways Today's Commodity-TV Video Interview /w GR

Top 8 Takeaways Today's Commodity-TV Video Interview /w GR
Top 8 takeaways from the Commodity-TV video interview with CEO George Robinson https://www.commodity-tv.net/?v=299207
 
  1. Producing at $1.25/gram CDN over 7000kg (7 tons) in Edmonton facility, this includes packaging to clients in Canada and in Europe a possible $5.50-7.99/gram per distribution channel.
  2. Norway joint venture with Biocare could see $100 million (Canadian $131 million) 50/50 split expansion into Europe, specifically Portugal. Backed by Norway’s sovereign fund and modelled on the oil and gas business and applying/diversifying into cannabis.
  3. 11,000kg Canadian production $50-60 CAD million, $70-80 CAD million for 2019, total Canadian and European production 46000kg $170 CAD million for 2020 and $200 EUR million into 2021-2022.
  4. 700 million people in the european market, government more agreeable to medical cannabis.
  5. 30% margin on cost structure/expansion rate.
  6. Only specific/strategic reason to finance otherwise sustain it out of the business.
  7. Orbital Gardens 2.0 growth cycle is 8 weeks vs 12-16 weeks for flat table and 6/year vs 4 for flat table.
  8. Grow room artificial intelligence (AI) quality measurements are hitting all targets for Health Canada recommendations. 
 
North seal oil money to invest almost twice RQB's market cap and split revenue of over $250 million per year by 2021 https://sevenpillarsinstitute.org/ethical-investing-norways-sovereign-wealth-fund/
 
"The Fund for example has guidelines for companies about children’s rights, climate change and water management"
 
<< Previous
Bullboard Posts
Next >>